Search

Search

Log in or registerMenuClose

Search

Rankings
Firms & Lawyers
In-House
- In-House Content
- GC Powerlist
Knowledge Centre
- About us

Comparative Guides
Events
Legal 500 TV

About us

Legal 500
FAQs
Marketing
Careers
Trust Centre
Contact us

Deutschland DE
Paris FR

Rankings
Firms & Lawyers
In-House
- In-House Content
- GC Powerlist
Knowledge Centre
- About us

Comparative Guides
Events
Legal 500 TV

About us

Legal 500
FAQs
Marketing
Careers
Trust Centre
Contact us

Deutschland DE
Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

Legal 500 Trust Centre
Contact Us

Market Intelligence
Search

3,511 results found

Use advanced search filters to refine your search

Search

2 filters applied

Advanced search filters

Topics

Search for topics

Countries

Search for countries

Contributor

Search to show contributors

Start typing to add contributors

Content type

Any
Article
Podcast
Video

Sort by

Article
Health Canada Publishes Final Guidance Documents On Quality Requirements For Regulatory Filings
Health Canada publishes final guidance documents on quality requirements for regulatory filings
CanadaFood, Drugs, Healthcare, Life Sciences
Smart & Biggar
Article
Is Your Distribution Arrangement Really A Franchise?
The provinces of Ontario, Alberta, Prince Edward Island, New Brunswick and Manitoba have each enacted franchise legislation which requires pre-sale disclosure to prospective franchisees in order to ensure that a prospective franchisee has the information necessary to make an informed investment decision.
CanadaFood, Drugs, Healthcare, Life Sciences

Gowling WLG

Le CEPMB publie son Rapport annuel sur les dépenses des régimes publics d'assurance médicaments (2022-2023)

Le 21 octobre 2025, le Conseil d'examen du prix des médicaments brevetés (CEPMB) a annoncé la publication de CompasRX (10e édition)...

CanadaFood, Drugs, Healthcare, Life Sciences

Legalization Of Recreational Marijuana (Cannabis) Use And Road Safety

There is much concern within the general public that the legalization of cannabis will lead to an increase in motor vehicle accidents.

CanadaFood, Drugs, Healthcare, Life Sciences

Howie, Sacks & Henry LLP

Navigating Canadian Cannabis Promotion Restrictions – The Swag Exception

Since the legalization of cannabis and the coming into force of the laws and regulations that govern the use, possession and sale of cannabis on October 17, 2018...

CanadaFood, Drugs, Healthcare, Life Sciences

Thompson Dorfman Sweatman LLP

Navigating The NHP-Food Transition

In fall 2011, Health Canada began charting a course for the transition of food-like Natural Health Products to the food regulatory framework.

CanadaFood, Drugs, Healthcare, Life Sciences

New Health Canada Guidelines On Health Product Advertising Versus Other Activities

Health Canada has published its long-awaited updated guidance on the distinction between advertising and other activities for health products. The updated guidance, published on the Health Canada website on July 31, 2023...

CanadaFood, Drugs, Healthcare, Life Sciences

Ontario Announces Its Cannabis Retail Model (Again)

When recreational cannabis becomes legal on October 17, 2018, Ontarians will no longer be driving out to their local Ontario Cannabis Store to get in line to purchase cannabis.

CanadaFood, Drugs, Healthcare, Life Sciences

Minden Gross LLP

PMPRB Proposes To Modify Guidelines Definition Of "gap Medicine" To Include Medicines Sold By July 1, 2021

As previously reported, regulations further amending the coming into force date of the Regulations Amending the Patented Medicines Regulations

CanadaFood, Drugs, Healthcare, Life Sciences

Proposed PMPRB Regulations Published For Comment

Amendments to the Patented Medicine Regulations (Proposed Regulations) were published for comment on December 1.

CanadaFood, Drugs, Healthcare, Life Sciences

Recent Amendments To The Canada Grain Act And Canada Grain Regulations

Changes are coming to the Canadian grain system as a result of the Canada-United States-Mexico Agreement ("CUSMA") which is set to come into effect on July 1, 2020. On June 23, 2020, the Canadian Grain Commission announced...

CanadaFood, Drugs, Healthcare, Life Sciences

Shoppers Drug Mart Inc. v. Ontario

In this case three judges of the Divisional Court ruled invalid two Ontario regulations which purported to prevent the sale of "private label" generic drugs.

CanadaFood, Drugs, Healthcare, Life Sciences

Craft Beer Trademarks: The Ol' Cease & Desist

Local Alberta breweries Elite Brewing (visited, love the carbon fibre bar) and Bow River Brewing have been on the receiving end of a cease and desist letter from the City of Calgary over a beer label for Fort Calgary ISA (a "richly hopped lighter bodied India session ale").

CanadaIntellectual Property

Federal Court Holds Compound Patent To Cinacalcet To Be Anticipated And Obvious

The Federal Court released its reasons in Amgen Canada Inc v Mylan Pharmaceuticals ULC on November 3, 2015.

CanadaIntellectual Property

Osler, Hoskin & Harcourt LLP

PM(NOC) Application Decisions: Patent Is Not Found To Be A Selection Patent, And Thus Was Anticipated And Obvious (Intellectual Property Weekly Abstracts Bulletin - Week of November 23, 2015)

The Federal Court has dismissed an application for prohibition to prevent the Minister of Health from issuing an NOC to Mylan for cinacalcet hydrochloride.

CanadaIntellectual Property

Borden Ladner Gervais LLP

PMPRB's Jurisdiction Limited To Patented Medicines

In the recent decision Galderma Canada Inc v. Canada (Attorney General) (2024 FCA 208), the Federal Court of Appeal (FCA) overturned decisions of the Federal Court and the Patented Medicine Prices...

CanadaIntellectual Property

Aird & Berlis LLP

$5.2 Million Settlement Reached In Canadian Farmed Atlantic Salmon Class Actions

A Canada-wide settlement has been reached in several proposed class actions alleging price fixing and related conduct on behalf of Canadians who purchased farmed Atlantic Salmon...

CanadaLitigation, Mediation & Arbitration

The Power Of An Inference: Federal Court Restores $125 Million S. 8 Damages Award

In Teva v. Pfizer Canada, 2017 FC 526, the Federal Court reaffirmed and reissued a judgment awarding Teva a section 8 damages award in excess of $125 million relating to the drug EFFEXOR XR® (venlafaxine).

CanadaLitigation, Mediation & Arbitration

McCarthy Tétrault

When is Aggregate Information Releasable and When is it Not?

The question frequently arises as to when aggregated or anonymized can be disclosed and when even with the aggregation or anonymization it is likely to disclose information that need to be protected.

Borden Ladner Gervais LLP

New BC Cannabis Legislation And Consequential Amendments To The Residential Tenancy Act

The Province of British Columbia has passed the Cannabis Control and Licensing Act (CCLA), which is scheduled to come into effect on October 17, 2018.

CanadaReal Estate and Construction

EKB | Edwards, Kenny & Bray LLP

Showing 901–920 of 3511 results

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics